Cadila Healthcare: Take care - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Cadila Healthcare: Take care

May 3, 2001

Cadila Healthcare Ltd. results are below our expectations. Though, year on year basis sales have grown by 6.5% (expected 10.5%), it has infact showed a negative growth (2.7%) on a sequential basis. Operating margins have dipped from 18% in Q3FY01 to a paltry 5.9% in Q4FY01. The sudden drop in operating margins is unexplained at this point of time. Thanks to substantial reduction in interest cost and income from parking of IPO funds, bottomline showed an apparent growth of 64%.

(Rs m) FY00 FY01 Change 3QFY01 4QFY01 Growth**
Sales 4,778 5,088 6.5% 1171 1139 -2.7%
Other Income 74 74 0.0% 25 -8 -132.0%
Expenditure 4,088 4,351 6.4% 960 1072 11.7%
Operating Profit (EBDIT) 690 737 6.8% 211 67 -68.2%
Operating Profit Margin (%) 14.4% 14.5% 0.3% 18.0% 5.9% -67.4%
Interest 213 (46) -121.6% 0 (57) -
Depreciation 99 149 50.5% 44 24 -45.5%
Profit before Tax 452 708 56.6% 192 92 -52.1%
Tax 53 55 3.8% 18 11 -38.9%
Profit after Tax/(Loss) 399 653 63.7% 174 81 -53.4%
Net profit margin (%) 8.4% 12.8%   14.9% 7.1%  
No. of Shares (eoy) (m) 60 60   60 60  
Diluted Earnings per share* 6.7 10.9   11.6 5.4  
P/E (at current price) 15.1 9.3        
(*- annualised)            
**- Sequential Growth            

In a related development , the company recently acquired a 27.7% stake in German Remedies at a cost of Rs 1.49 bn. The acquisition was effectively valued at 2.4 times German Remedies sales. It also acquired perpetual rights to market five leading brands from Asta (one of the promoter of German Remedies). The financing of the same would be done through a mix of debt (Rs 2,000 m) and internal accruals. The company expects to leverage this acquisition to enter high margin therapeutic segments like respiratory, gynaecology and oncology, where German Remedies has a strong presence.

Particulars Cadila Sun Pharma Cipla
CMP (Rs.) 101 550 1,127
Sales (In Rs. Mn) 5,088 6,132 10,477
Growth (YoY) 6.5% 28.1% 38.0%
Operating Profit Margins 14.5% 24.6% 20.6%
P/e (FY 2001) (x) 9.3 19 38
Market Capitalisation (In Rs Mn) 6,060 24,853 67,577
Market Cap/Sales (x) 1.2 4.1 6.5

At the current market price of Rs 101, the stock is valued at 9.3 times its FY01 earnings and 1.2 times its current market capitalisation to sales. The prospects of the company would depend on how fast the ambitious acquisitions pays off. The company also needs to gear up growth, particularly given the fact that its peers like Sun Pharma are growing at much faster rates.

Equitymaster requests your view! Post a comment on "Cadila Healthcare: Take care". Click here!


More Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

How Much Money Do You Need to Be a Professional Trader? (Fast Profits Daily)

Sep 17, 2020

In this video I'll answer a question I get asked often: How much capital do I really need to trade the markets for a living? Let's find out...


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Sep 25, 2020 (Close)


  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks